Compare TMDX & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | CENT |
|---|---|---|
| Founded | 1998 | 1955 |
| Country | United States | United States |
| Employees | N/A | 6000 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 2019 | N/A |
| Metric | TMDX | CENT |
|---|---|---|
| Price | $83.33 | $44.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $148.22 | $50.00 |
| AVG Volume (30 Days) | ★ 937.7K | 80.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 382.18 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $605,494,000.00 | N/A |
| Revenue This Year | $24.25 | $1.60 |
| Revenue Next Year | $18.75 | $2.04 |
| P/E Ratio | $131.49 | ★ $15.73 |
| Revenue Growth | ★ 37.13 | N/A |
| 52 Week Low | $60.11 | $28.77 |
| 52 Week High | $156.00 | $46.67 |
| Indicator | TMDX | CENT |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 67.42 |
| Support Level | $66.18 | $42.32 |
| Resistance Level | $140.79 | N/A |
| Average True Range (ATR) | 4.14 | 1.46 |
| MACD | 0.63 | 0.12 |
| Stochastic Oscillator | 79.36 | 98.10 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.